Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence

Clinical trial NCT02032368 · COMPLETED

Trial details

NCT number: NCT02032368
Sponsor: Guangdong Provincial People's Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Circulating Tumor Cell;Hepatocellular Carcinoma

Start date: 2010-07-01
Primary completion: 2012-12-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.